The U.S. Food and Drug Administration is collaborating with patients, academics, and the pharmaceutical industry to encourage the development of new treatments for sickle cell disease (SCD).
via FDA Consumer Health Information Updates http://ift.tt/2xgZVOC
No comments:
Post a Comment